These emerging treatments , including Semaglutide , belong to a group of drugs called GLP-1 mimics . Initially developed for managing type 2 diabetes , they operate by helping the body to produce more the hormone insulin and curbing excessive sugar levels. Beyond gop1 diabetes, their ability to support slimming has contributed to significant discus